Teva Pharmaceuticals USA recalls Metoprolol Succinate Extended Release Tablets, USP 50 mg, 100-count bottle, Rx only, Manufactured by: Actavis Laboratori
Recalled October 31, 2018 · FDA recall D-0129-2019 · Teva Pharmaceuticals USA
Hazard
Failed dissolution specifications: Out-of-Specification dissolution test result obtained during routine stability testing. · FDA Class II
Units
53,451 bottles
Sold at
U.S.A. Nationwide including Puerto Rico.
Description
Failed dissolution specifications: Out-of-Specification dissolution test result obtained during routine stability testing.
Product
Metoprolol Succinate Extended Release Tablets, USP 50 mg, 100-count bottle, Rx only, Manufactured by: Actavis Laboratories FL, Inc., Fort Lauderdale, FL 33314, Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054, NDC 62037-831-01
Manufacturer(s)
Teva Pharmaceuticals USA
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →